Orbimed Advisors as of Dec. 31, 2024
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 112 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Edgewise Therapeutics (EWTX) | 8.2 | $401M | 15M | 26.70 | |
| Sinovac Biotech SHS | 6.9 | $334M | 2.7M | 122.85 | |
| Boston Scientific Corporation (BSX) | 5.8 | $282M | 3.2M | 89.32 | |
| Eli Lilly & Co. (LLY) | 5.4 | $261M | 338k | 772.00 | |
| Intuitive Surgical Com New (ISRG) | 4.3 | $210M | 402k | 521.96 | |
| Enliven Therapeutics (ELVN) | 3.7 | $179M | 8.0M | 22.50 | |
| Neurocrine Biosciences (NBIX) | 2.6 | $128M | 938k | 136.50 | |
| Stryker Corporation (SYK) | 2.5 | $124M | 344k | 360.05 | |
| Sarepta Therapeutics (SRPT) | 2.4 | $117M | 963k | 121.59 | |
| Argenx Se Sponsored Adr (ARGX) | 2.4 | $117M | 190k | 615.00 | |
| Disc Medicine (IRON) | 2.3 | $113M | 1.8M | 63.40 | |
| Tenet Healthcare Corp Com New Call Option (THC) | 2.1 | $103M | 817k | 126.23 | |
| Ionis Pharmaceuticals (IONS) | 2.0 | $99M | 2.8M | 34.96 | |
| Alnylam Pharmaceuticals (ALNY) | 2.0 | $98M | 416k | 235.31 | |
| Upstream Bio (UPB) | 1.9 | $94M | 5.7M | 16.44 | |
| Silverback Therapeutics (SPRY) | 1.8 | $87M | 8.3M | 10.55 | |
| Edwards Lifesciences (EW) | 1.7 | $85M | 1.1M | 74.03 | |
| Merck & Co (MRK) | 1.7 | $83M | 830k | 99.48 | |
| Arrivent Biopharma (AVBP) | 1.7 | $81M | 3.0M | 26.64 | |
| Biogen Idec (BIIB) | 1.6 | $78M | 509k | 152.92 | |
| Integer Hldgs (ITGR) | 1.6 | $76M | 575k | 132.52 | |
| Cytokinetics Com New (CYTK) | 1.5 | $75M | 1.6M | 47.04 | |
| Mbx Biosciences (MBX) | 1.4 | $70M | 3.8M | 18.43 | |
| UnitedHealth (UNH) | 1.4 | $66M | 131k | 505.86 | |
| Natera (NTRA) | 1.3 | $65M | 413k | 158.30 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.3 | $61M | 151k | 402.70 | |
| Third Harmonic Bio (THRD) | 1.2 | $60M | 5.8M | 10.29 | |
| Universal Hlth Svcs CL B Call Option (UHS) | 1.2 | $57M | 319k | 179.42 | |
| Si-bone Call Option (SIBN) | 1.1 | $52M | 3.7M | 14.02 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $51M | 999k | 51.13 | |
| Springworks Therapeutics (SWTX) | 0.9 | $45M | 1.3M | 36.13 | |
| Thermo Fisher Scientific (TMO) | 0.9 | $44M | 84k | 520.23 | |
| Terns Pharmaceuticals (TERN) | 0.9 | $42M | 7.6M | 5.54 | |
| Gilead Sciences Call Option (GILD) | 0.8 | $41M | 446k | 92.37 | |
| Cg Oncology (CGON) | 0.8 | $41M | 1.4M | 28.68 | |
| Janux Therapeutics (JANX) | 0.8 | $41M | 759k | 53.54 | |
| EXACT Sciences Corporation (EXAS) | 0.8 | $38M | 680k | 56.19 | |
| Neuropace (NPCE) | 0.8 | $38M | 3.4M | 11.19 | |
| Xenon Pharmaceuticals (XENE) | 0.8 | $37M | 948k | 39.20 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $37M | 6.9M | 5.35 | |
| Spdr Ser Tr S&p Biotech (XBI) | 0.7 | $34M | 372k | 90.06 | |
| Compass Therapeutics (CMPX) | 0.7 | $32M | 22M | 1.45 | |
| Xtant Med Hldgs Com New (XTNT) | 0.7 | $32M | 73M | 0.44 | |
| Avidity Biosciences Ord (RNA) | 0.7 | $32M | 1.1M | 29.08 | |
| Vera Therapeutics Cl A (VERA) | 0.6 | $31M | 743k | 42.29 | |
| Dyne Therapeutics (DYN) | 0.6 | $29M | 1.2M | 23.56 | |
| Cullinan Oncology (CGEM) | 0.5 | $24M | 1.9M | 12.18 | |
| Vir Biotechnology (VIR) | 0.5 | $24M | 3.2M | 7.34 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $22M | 400k | 55.98 | |
| Immatics SHS (IMTX) | 0.5 | $22M | 3.1M | 7.11 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $22M | 802k | 27.12 | |
| Amicus Therapeutics (FOLD) | 0.4 | $22M | 2.3M | 9.42 | |
| Scpharmaceuticals (SCPH) | 0.4 | $22M | 6.1M | 3.54 | |
| Rapt Therapeutics | 0.4 | $21M | 13M | 1.58 | |
| Tyra Biosciences (TYRA) | 0.4 | $20M | 1.5M | 13.90 | |
| Mineralys Therapeutics (MLYS) | 0.4 | $20M | 1.6M | 12.31 | |
| Ikena Oncology Nonvoting | 0.4 | $20M | 12M | 1.64 | |
| C4 Therapeutics Com Stk (CCCC) | 0.3 | $16M | 4.5M | 3.60 | |
| Keros Therapeutics (KROS) | 0.3 | $16M | 1.0M | 15.83 | |
| Medpace Hldgs (MEDP) | 0.3 | $15M | 45k | 332.23 | |
| Verastem Com New (VSTM) | 0.3 | $15M | 2.9M | 5.17 | |
| Prelude Therapeutics (PRLD) | 0.3 | $14M | 11M | 1.27 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.3 | $14M | 1.2M | 11.80 | |
| Forte Biosciences Com New (FBRX) | 0.3 | $14M | 600k | 22.71 | |
| Intra Cellular Therapies (ITCI) | 0.3 | $14M | 163k | 83.52 | |
| Acelyrin | 0.3 | $13M | 4.0M | 3.14 | |
| Abcellera Biologics (ABCL) | 0.3 | $12M | 4.2M | 2.93 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $12M | 6.0M | 1.99 | |
| Adicet Bio (ACET) | 0.2 | $11M | 11M | 0.96 | |
| Pmv Pharmaceuticals (PMVP) | 0.2 | $9.8M | 6.5M | 1.51 | |
| Neumora Therapeutics (NMRA) | 0.2 | $8.5M | 805k | 10.60 | |
| Q32 Bio (QTTB) | 0.2 | $7.8M | 2.3M | 3.44 | |
| Geron Corporation (GERN) | 0.2 | $7.7M | 2.2M | 3.54 | |
| Avalo Therapeutics Com New (AVTX) | 0.1 | $7.2M | 967k | 7.43 | |
| Cardiff Oncology (CRDF) | 0.1 | $6.7M | 1.5M | 4.34 | |
| Pfizer Call Option (PFE) | 0.1 | $6.6M | 250k | 26.53 | |
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $6.6M | 152k | 43.22 | |
| Insmed Com Par $.01 (INSM) | 0.1 | $6.5M | 95k | 69.04 | |
| Engene Holdings (ENGN) | 0.1 | $6.1M | 920k | 6.65 | |
| Ikena Oncology (IKNA) | 0.1 | $5.8M | 3.5M | 1.64 | |
| Inspiremd (NSPR) | 0.1 | $5.6M | 2.1M | 2.63 | |
| Traws Pharma Com New (TRAW) | 0.1 | $5.4M | 606k | 8.88 | |
| Bioage Labs (BIOA) | 0.1 | $5.3M | 922k | 5.79 | |
| X4 Pharmaceuticals | 0.1 | $5.2M | 7.1M | 0.73 | |
| Bicara Therapeutics (BCAX) | 0.1 | $5.2M | 298k | 17.42 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $4.7M | 2.0M | 2.36 | |
| Repare Therapeutics Ord (RPTX) | 0.1 | $4.4M | 3.3M | 1.31 | |
| Passage Bio | 0.1 | $4.2M | 7.4M | 0.57 | |
| Krystal Biotech (KRYS) | 0.1 | $3.7M | 24k | 156.66 | |
| Ardent Health Partners (ARDT) | 0.1 | $3.5M | 206k | 17.08 | |
| Chemomab Therapeutics Sponsored Ads | 0.1 | $3.2M | 1.7M | 1.81 | |
| Ceribell (CBLL) | 0.1 | $2.9M | 113k | 25.88 | |
| Fate Therapeutics (FATE) | 0.1 | $2.8M | 1.7M | 1.65 | |
| Pepgen (PEPG) | 0.1 | $2.5M | 653k | 3.79 | |
| Instil Bio Com New (TIL) | 0.0 | $2.2M | 117k | 19.09 | |
| Nkarta (NKTX) | 0.0 | $2.0M | 821k | 2.49 | |
| Lyell Immunopharma | 0.0 | $2.0M | 3.1M | 0.64 | |
| Immunovant (IMVT) | 0.0 | $1.9M | 79k | 24.77 | |
| Akero Therapeutics (AKRO) | 0.0 | $1.8M | 66k | 27.82 | |
| Tango Therapeutics (TNGX) | 0.0 | $1.7M | 550k | 3.09 | |
| Turnstone Biologics Corp (TSBX) | 0.0 | $1.5M | 3.1M | 0.50 | |
| Amylyx Pharmaceuticals (AMLX) | 0.0 | $1.3M | 348k | 3.78 | |
| Biomx Com New (PHGE) | 0.0 | $1.3M | 1.8M | 0.73 | |
| Kezar Life Sciences Com New (KZR) | 0.0 | $1.3M | 193k | 6.72 | |
| Korro Bio (KRRO) | 0.0 | $1.2M | 32k | 38.07 | |
| Alto Neuroscience Com Shs (ANRO) | 0.0 | $1.1M | 250k | 4.23 | |
| Nextcure (NXTC) | 0.0 | $880k | 1.1M | 0.77 | |
| Agios Pharmaceuticals (AGIO) | 0.0 | $877k | 27k | 32.86 | |
| Elevation Oncology (ELEV) | 0.0 | $530k | 941k | 0.56 | |
| Adagio Therapeutics (IVVD) | 0.0 | $509k | 1.1M | 0.44 | |
| Lakeshore Biopharma Ord Shs New (LSBCF) | 0.0 | $486k | 140k | 3.46 | |
| Xeris Pharmaceuticals (XERS) | 0.0 | $273k | 80k | 3.39 |